-
Voxel-Based Morphometry Reveals Gray Matter Volume Reductions in Sporadic Dystonia
-
VPS13A Disease: 15 Years of Illness Awaiting a Diagnosis
-
VPS13C Heterozygous Variant as a Potential Modifier in AARS1-Related Charcot-Marie-Tooth Disease with Parkinson’s Disease
-
Wearable assessment of levodopa-entacapone-carbidopa intestinal gel treatment characteristics at home: Pilot Protocol
-
Wearable Gait Metrics as Potential Digital Biomarkers in GBA1 Non-Manifesting Carriers
-
Wearable IMU-Based Gait Analysis Reveals Pharmacological Freezing-of-Gait Phenotypes in Parkinson Disease: A Longitudinal Two-Visit Study
-
Wearable Sensors Identify Mobility Features Associated With Parkinson’s Disease Years Before Clinical Diagnosis
-
Wearable-Derived Cardiac Features and Cardiac–Motor Interconnection Across Parkinson’s Disease Severities
-
Wearable-Derived Gait Biomarkers Predict Disease Severity and Quality of Life in Parkinson’s Disease: A Machine Learning and Mediation Analysis
-
Weight and Body Mass Index Changes in Parkinson’s Disease and Their Association with Disease Progression: A Two-Year Longitudinal Study
2026 International Congress
October 4-8, 2026. Seoul, Korea.